New Share and Voting Rights Report for Innate Pharma

Innate Pharma, a company listed on Euronext Paris and Nasdaq, announces that as of December 31, 2024 it holds 83,830,336 ordinary shares, as well as 6,494 2016 Preference Shares and 7,581 2017 Preference Shares. The total number of theoretical voting rights reaches 84,585,576, while 84,567,001 voting rights are exercisable.

Theoretical rights include shares without voting rights, serving as a basis for threshold crossings. Exercisable, or "net", rights exclude shares held in treasury by the company. This press release complies with the AMF's recommendations to ensure clear information for investors.

This information allows stakeholders to have a precise vision of the shareholder structure of Innate Pharma.